Medicine Alemtuzumab – Alemtuzumab Drug Information

Alemtuzumab binds to CD52, an antigen is present on the surface nonmodulating essentially all B and T lymphocytes, the majority of monocytes, macrophages and NK cells and a subpopulation of granulocytes. The proposed mechanism of action dependent lysis antibodies to leukemia cells after cell surface binding. The maximum plasma concentration and AUC showed dose proportionality relative.

Alemtuzumab has been associated with infusion-related events including hypotension, chills, fever, difficulty breathing, bronchospasm, chills or rash. To improve or prevent infusion related events, patients premedicated with an oral antihistamine and acetaminophen before management and closely monitored.

In addition, the low-dose alemtuzumab open with a gradual increase of the effective dose. Careful control of pressure pressure and low blood pressure symptoms is recommended, especially in patients with ischemic heart disease and patients on treatment for hypertension. If you stop treatment for at least 7 days, increasing doses of alemtuzumab restored.

How alemtuzumab

Alemtuzumab Take exactly as prescribed by the care provider. Alemtuzumab is usually commercially available as powder for injection, 7.5 mg lyophilized avoid shaking the vial before use. Discard vial if the solution has been frozen.Dilute in 100 ml sodium chloride 0.9% or dextrose 5%. Mix the solution by gently inverting the bag. Diluted solutions are preservative-free and must be used within 24 hours to reduce the risk of microbial contamination. The manufacturer recommends the use of 8 hours.

Indications of drug alemtuzumab

Refractory B-cell chronic lymphocytic leukemia. If the patient reaction, the infusion can continue at the same rate, at the discretion of the physician. Interruption infusion or temporarily reduce the rate of severe reactions, including hypotension, hypertension, difficulty breathing or a rash. Symptoms may be treated with hydrocortisone (eg, Solu-Cortef) 200 mg IV, diphenhydramine (Benadryl, for example), acetaminophen (eg Tylenol), bronchodilators, oxygen or intravenous fluids. Monitor the patient until the symptoms disappear completely. Patients who responded to alemtuzumab infusions can receive additional doses. Hydrocortisone or equivalent with corticosteroids may be added to the pretreatment system discretion of the physician.
Contra-indications for drug alemtuzumab

Patients who are allergic to alemtuzumab, patients active systemic infections, and patients with underlying immune deficiency.

What are the Side effects of alemtuzumab –

Like other medicines, alemtuzumab may cause side effects. Some of the most common side effects of alemtuzumab include

* Hypotension, peripheral edema, hypertension, supraventricular tachycardia.
Fatigue, headache, dysesthesia, weakness, dizziness, insomnia.
* Skin rash, urticaria, pruritus, increased sweating.
* Moderate to low potential for nausea and vomiting, diarrhea, anorexia, mucositis;, abdominal pain and dyspepsia common.
* The myelosuppression (80% to 85%) fatal pancytopenia, marrow hypoplasia, autoimmune anemia, autoimmune thrombocytopenia.
* Shortness of breath, cough, bronchitis, or pneumonia, pneumonia, pharyngitis.
* Chills and fever over 80% of patients during infusion or within 45 to 60 minutes. Nausea, vomiting, rash, urticaria, dyspnea, hypotension, chills and can also occur.
* Pain bones, myalgia, back pain, chest pain.

Warnings and precautions before taking alemtuzumab:

* Graves or death (rare), pancytopenia, bone marrow hypoplasia, autoimmune idiopathic thrombocytopenia and autoimmune hemolytic anemia occurred prior to use alemtuzumab.
* Graves, opportunistic infections sometimes fatal (bacterial, viral, fungi and protozoa) reported.
* Advise women before using alemtuzumab to inform the doctor if you are pregnant, planning to become pregnant or taking alemtuzumab. Insulin is recommended to maintain glucose levels in the blood during pregnancy. Prolonged severe neonatal hypoglycemia can occur if sulfonylureas are administered at the time of delivery.
* Women of childbearing age and men of reproductive health before using Alemtuzumab has the potential to use effective contraception during treatment and for at least 6 months after alemtuzumab treatment.
* Avoid vaccinations with live vaccines attenuated during this period, including BCG, measles, mumps, rubella, typhoid Ty21a, varicella, yellow fever, and others.

What if an overdose of alemtuzumab?

If you think you or someone else alemtuzumab overdose, call your doctor or contact with your local poison control center or regional medical advice immediately. You may need urgent medical attention. Chills, headache, arthralgia, sinusitis can be symptoms of an overdose alemtuzumab.
What if Missed Dose of alemtuzumab?

If you miss a dose of alemtuzumab and one hour recalls or two, take the dose immediately. If you do not remember later, skip the missed dose and resume your regular schedule. Do not double doses.

Storage Conditions to alemtuzumab:

Refrigerate, Do not freeze. Protect from direct sunlight. Shop Alemtuzumabat dilute solutions at room temperature or in refrigerator. Protect from light. Alemtuzumabat dilute solutions are condoms and should be used within 24 hours to reduce the risk of microbial contamination. The manufacturer recommends use within 8 hours.

By: ASHU

About the Author

For More Article Of This Author Visit :: http://www.thearticleinsiders.com/